文献速递妇科

BRCA1胚系突变个体腹膜冲洗液中TP53体细胞演化增加

Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations.
PubMed 文献 · Gynecol Oncol · 2024-08-10

研究对60例BRCA1/BRCA2携带者及非携带者的腹膜冲洗液和宫颈液基细胞学(LBC)行双链测序检测TP53突变。腹膜冲洗液中致病性TP53突变负荷在BRCA1携带者较非携带者升高且不依赖年龄;部分个体腹膜冲洗液与宫颈LBC共享相同致病突变但血液中未检出。

要点

  • 腹膜冲洗液中致病性TP53突变负荷在BRCA1携带者较非携带者升高,且不依赖年龄。
  • 宫颈LBC中TP53突变较腹膜冲洗液更丰富,但两组间致病性突变负荷未见BRCA1相关升高。
  • 5例个体腹膜冲洗液与宫颈LBC共享相同致病性TP53突变,血液中未检出。

核心结论

  • 手术时采集的腹膜冲洗液超深度测序显示BRCA1携带者致病性TP53突变负荷增加,可能与高级别浆液性卵巢癌(HGSC)风险升高相关。
  • 部分患者腹膜冲洗液与宫颈LBC检出相同TP53突变,但细胞来源未知,值得进一步研究。

研究设计与样本

  • 采用双链测序(Duplex sequencing)高灵敏度检测TP53突变。
  • 样本为手术时采集的腹膜冲洗液和宫颈液基细胞学(LBC),共60例个体,包括BRCA1和BRCA2携带者及非携带者。

主要发现

  • TP53突变在宫颈LBC中较腹膜冲洗液更丰富,但在两种样本类型中均随年龄增加。
  • 腹膜冲洗液中致病性TP53突变负荷在BRCA1携带者较非携带者升高,且不依赖年龄;宫颈LBC中未见此差异。
  • 5例个体腹膜冲洗液与宫颈LBC共享相同致病性TP53突变,血液中未检出。

局限性

  • 部分患者腹膜冲洗液与宫颈LBC检出相同TP53突变,但细胞来源未知,值得进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individuals with germline BRCA1 and BRCA2 pathogenic variants (BRCA carriers) are at high risk of developing high grade serous ovarian carcinoma (HGSC). HGSC is predominantly driven by TP53 mutations, but mutations in this gene are also commonly found in non-cancerous tissue as a feature of normal human aging. We hypothesized that HGSC predisposition in BRCA carriers may be related to increased TP53 somatic evolution, which could be detectable by ultra-deep sequencing of TP53 mutations in gynecological liquid biopsies. METHODS: Duplex sequencing was used to identify TP53 mutations with high sensitivity in peritoneal washes and cervical liquid-based cytology (LBC) collected at surgery from 60 individuals including BRCA1 and BRCA2 carriers, and non-carriers. TP53 mutation pathogenicity was compared across groups and with TP53 cancer mutations. RESULTS: TP53 mutations were more abundant in cervical LBC than in peritoneal washes but increased with age in both sample types. In peritoneal washes, but not in cervical LBC, pathogenic TP53 mutation burden was increased in BRCA1 carriers compared to non-carriers, independently of age. Five individuals shared identical pathogenic TP53 mutations in peritoneal washes and cervical LBC, but not in blood. CONCLUSIONS: Ultra-deep sequencing of TP53 mutations in peritoneal washes collected at surgery reveals increased burden of pathogenic TP53 mutations in BRCA1 carriers. This excess of pathogenic TP53 mutations might be linked to the elevated risk of HGSC in these individuals. In some patients, concordant TP53 mutations were found in peritoneal washes and cervical LBCs, but the cell of origin remains unknown and deserves further investigation.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Tee XR, Hazard E, Latorre-Esteves E, et al. Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations. Gynecol Oncol. 2024. PMID: 39128337. doi:10.1016/j.ygyno.2024.07.690

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。